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Transcatheter Arterial Embolization of
Nonvariceal Upper Gastrointestinal
Bleeding with N-Butyl Cyanoacrylate
Objective: To evaluate the clinical efficacy and safety of transcatheter arterial
embolization (TAE) with N-Butyl Cyanoacrylate (NBCA) for nonvariceal upper
gastrointestinal bleeding.
Materials and Methods: Between March 1999 and December 2002, TAE for
nonvariceal upper gastrointestinal bleeding was performed in 93 patients. The
endoscopic approach had failed or was discarded as an approach for control of
bleeding in all study patients. Among the 93 patients NBCA was used as the pri-
mary embolic material for TAE in 32 patients (28 men, four women; mean age,
59.1 years). The indications for choosing NBCA as the embolic material were:
inability to advance the microcatheter to the bleeding site and effective wedging
of the microcatheter into the bleeding artery. TAE was performed using 1:1 1:3
mixtures of NBCA and iodized oil. The angiographic and clinical success rate,
recurrent bleeding rate, procedure related complications and clinical outcomes
were evaluated.
Results: The angiographic and clinical success rates were 100% and 91%
(29/32), respectively. There were no serious ischemic complications. Recurrent
bleeding occurred in three patients (9%) and they were managed with emergency
surgery (n = 1) and with a successful second TAE (n = 2). Eighteen patients
(56%) had a coagulopathy at the time of TAE and the clinical success rate in this
group of patients was 83% (15/18). 
Conclusion: TAE with NBCA is a highly effective and safe treatment modality
for nonvariceal upper gastrointestinal bleeding, especially when it is not possible
to advance the microcatheter to the bleeding site and when the patient has a
coagulopathy. 
ranscatheter arterial embolization (TAE) has been widely used to control
nonvariceal upper gastrointestinal bleeding (1 4). A variety of embolic
materials have been used for embolization; the more commonly used
agents are gelatin sponge pieces, coils and polyvinyl alcohol particles. However, liquid
embolic materials such as N-Butyl Cyanoacylate (NBCA) have been rarely used,
because of concerns about complicated ischemic injury and difficulty with handling the
materials.
N-Butyl Cyanoacylate has several advantages compared with other embolic materi-
als. NBCA allows rapid and permanent embolization with fast polymerization when
contacted with blood. Complete hemostasis can be achieved by a single injection with
simultaneous embolization of collateral vessels connected to the bleeding focus, which
can cause backbleeding or rebleeding if not treated. NBCA is also useful in patients
with coagulopathy because it does not depend on the coagulation process for its
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Table 1. Clinical Data on 32 Patients Who Underwent Embolization with the NBCA Mixture
No Sex Age Underlying Coagulo- Angiographic  Vessel  Embolic  Rebleeding Follow-
Condition pathy Findings Embolized Materials Up
1 M 51 GU No Pseudoanurysm RGA NBCA No Discharged 
2 M 84 Gastric cancer No Extravasation LGA NBCA No Discharged 
3 M 58 Lung cancer, GU No Extravasation LGA NBCA No Discharged 
4 M 51 Gastric cancer No Extravasation LGA NBCA No Discharged 
5 M 45 DU Yes Extravasation Duodenal branch  NBCA No Discharged 
from GDA
6 M 62 Adenocarcinoma of  No Extravasation RGA NBCA No Discharged 
unknown primary 
site, GU
7 F 57 Esophageal  Yes Extravasation Esophageal branch  NBCA No 4 days: death, 
candidiasis from thoracic aorta septic shock
8 M 64 Subtotal gastrectomy  Yes Extravasation Esophageal branch  NBCA No 4 weeks: death, 
state due to gastric  from LIPA septic shock
cancer, marginal ulcer
9 M 43 Lymphoma, DU Yes Extravasation Duodenal branch  10 days: death, 
from GDA NBCA No septic shock
10 M 57 DM, ESRD, Duodenal  Yes Extravasation Duodenal branch  NBCA No Discharged 
tuberculosis from GDA
11 M 63 LC with HCC, GU Yes Extravasation LGA NBCA No Discharged 
12 M 60 LC, GU Yes Extravasation RGA NBCA No Discharged 
13 M 67 Duodenal cancer  No Pseudoanurysm Duodenal branch  NBCA No 16 days: death, 
with liver metastasis from GDA MOF
14 F 65 Toxic hepatitis, DU Yes Extravasation Duodenal branch  NBCA 1 day :  30 days: death,
from GDA rebleeding  hepatic failure
hemostasis with 
second TAE 
with Gelfoam 
15 M 59 Lung cancer, DU No Extravasation Duodenal branch  NBCA No Discharged 
from GDA
16 M 59 Gastric cancer No Pseudoanurysm Right GEA  NBCA No 4 weeks: 
cancer surgery 
17 M 73 CVA, DU No Extravasation Duodenal branch  NBCA No Discharged 
from GDA
18 M 38 Necrotizing pancreatitis Yes Extravasation Dorsal pancreatic   NBCA No 11 days: death, 
artery from SMA septic shock
19 M 59 DM, ESRD, DU Yes Extravasation Duodenal branch  NBCA No Discharged 
from GDA
20 M 75 GU Yes Extravasation LGA NBCA 1 day: rebleeding  Discharged 
emergency 
surgery
21 M 62 Chronic pancreatitis Yes Pseudoanurysm Transverse  NBCA,  No Discharged 
pancreatic artery microcoil for 
proximal 
blockade
22 F 42 Gastric cancer No Extravasation LGA NBCA No 8 weeks: death, 
MOF
23 M 66 Chronic osteomyelitis  No Extravasation Duodenal branch  NBCA No Discharged 
of right femur, DU from GDA 
24 M 61 DM, Parapharyngeal  Yes Extravasation Duodenal branch  NBCA 2 days: rebleeding Discharged 
abscess, DU from GDA hemostasis with 
second TAE 
with NBCA
continuetherapeutic effect. Serious complications, such as bowel
ischemia or innocent vessel embolization, can be minimized
by treating patients with appropriate indications and careful
procedures by adequately trained interventionists. 
Thus, NBCA can be an alternative embolic material
which is effective, rapid and safe in transcatheter emboliza-
tion of gastrointestinal bleeding and it may possibly be
lifesaving in very emergent situations, especially when the
patient is critical. The purpose of this study was to evaluate
the clinical efficacy and safety of TAE with NBCA for
nonvariceal upper gastrointestinal bleeding that could not
be controlled by conventional endoscopic procedures. 
MATERIALS AND METHODS
Study Subjects
Between March 1999 and December 2002, TAE for
nonvariceal upper gastrointestinal bleeding was performed
in 93 patients at our institution. The endoscopic approach
had failed or was discarded because of its inability to
control the bleeding in participating patients. Prospective
collection of data about clinical records and medical
imagings was carried out for all patients. Among the 93
patients, NBCA was used as the primary embolic material
for TAE in 32 patients and they were included in this
study. There were 28 men and four women, with an age
range of 33 84 years (mean age, 59.1 years). Pertinent
patient information including comorbid conditions are
summarized in the Table 1. The causes of bleeding
included: benign ulcers (n = 20), gastric cancers (n = 7),
pancreatitis (n = 2), duodenal cancer (n = 1), duodenal
tuberculosis (n = 1) and esophageal candidiasis (n = 1). The
embolized arteries were: duodenal branch of gastroduode-
nal arteries (n = 11), left gastric arteries (n = 9), right
gastric arteries (n = 5), right gastroepiploic arteries (n = 2),
esophageal arteries (n = 2), antral branch of gastroduode-
nal artery (n = 1), dorsal pancreatic artery (n = 1) and the
transverse pancreatic artery (n = 1). The angiographic
findings were extravasation of contrast media in 27
patients and pseudoaneurysms in five patients. Written
informed consent for transcatheter embolization was
obtained from each patient or a family member. 
Embolization Techniques 
N-Butyl Cyanoacrylate (Histoacryl, Braun, Melsungen,
Germany) was used as an embolic agent in all participating
patients. After a common femoral artery puncture, a
standard 5-F angiographic catheter was used to access the
sites of suspected bleeding and it was also used as an
introducing catheter. Diagnostic angiography was
performed to identify the bleeding site; next a 3-F
microcatheter (Microferret; Cook, Bloomington, IN) was
advanced, to as close as possible, to the bleeding point. The
indications for using NBCA as an embolic material were
inability to adequately reach the bleeding site and effective
wedging of the microcatheter into the bleeding artery to
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No Sex Age Underlying Coagulo- Angiographic  Vessel  Embolic  Rebleeding Follow-
Condition pathy Findings Embolized Materials Up
25 M 64 Gastric cancer No Extravasation LGA NBCA,  No Discharged 
Gelfoam for 
collateral 
blockade
26 M 61 GU Yes Pseudoaneurysm RGA NBCA, No Discharged 
microcoil for 
proximal 
blockade
27 M 42 Gastric cancer No Extravasation RGA NBCA No Discharged 
28 M 62 GU Yes Extravasation LGA NBCA No Discharged 
29 M 33 Liver transplantation,  Yes Extravasation Antral branch  NBCA No Discharged 
GU from GDA
30 M 55 Gastric cancer Yes Extravasation Right GEA NBCA No 2 days: cancer 
surgery 
31 F 79 DU Yes Extravasation Duodenal branch  NBCA No Discharged 
from GDA
32 M 74 GU No Extravasation LGA NBCA No Discharged 
Note. GU = gastric ulcer, DU = duodenal ulcer, DM = diabetes mellites, ESRD = end stage renal disease, LC = liver cirrhosis, HCC = hepatocellular 
carcinoma, CVA = cerebrovascular accident, RGA = right gastric artery, LIPA = left inferior phrenic artery, GDA = gastroduodenal artery, LGA = left gastric
artery, GEA = gastroepiploic artery, SMA = superior mesenteric artery, NBCA = N-Butyl Cyanoacrylate, TAE = transcatheter arterial embolization, MOF =
multi-organ failurerestrict pericatheter flow (Figs. 1, 2). 
For the embolotherapy, NBCA was mixed with iodized
oil (Lipiodol, Andre Guerbet, Aulnay-Sous-Bois, France) in
ratios varying from 1:1 to 1:3; the iodized oil supplied
radiopacity to the mixture and delayed the polymerization
time (5). Prior to injection of the NBCA mixture, the
microcatheter was flushed with 5% dextrose solution to
prevent premature polymerization of the mixture in
contact with residual blood or saline. The NBCA mixture
was injected using a 1 mL syringe under careful fluoro-
scopic monitoring. The end point for the injection was
extravasation of the mixture from the bleeding site or
filling of the pseudoaneurysm with or without appearance
of anastomotic channels (Fig. 3). Only a small amount of
NBCA mixture (0.2 0.6 mL) was necessary to achieve
target embolization. Immediately after the injection, the
microcatheter was removed to prevent adherence of the
catheter tip to the vessel wall and discarded without
flushing. Then the inner lumen of the guiding catheter was
aspirated and post-embolic angiography was performed.
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Fig. 1. Thirty-three-year-old male presented with gastric ulcer bleeding who underwent liver transplantation 11 days previously.
A. Celiac arteriography shows suspected extravasation of contrast media in the antrum of the stomach (arrow).
B. Superselective gastroduodenal arteriography using a microcatheter reveals extravasation of contrast media from the antral branch
(arrow). 
C. Radiography obtained after test injection of contrast media. The tip of the microcatheter (white arrow) could not advance to the
bleeding point, but effective wedging of the microcatheter, into the bleeding artery, was achieved to restrict pericatheter flow.
D. Post-embolic celiac arteriography shows the successful embolization of the bleeding focus after embolization with NBCA mixture.
CDAnalysis 
The angiographic and clinical success rate, recurrent
bleeding rate, procedure related complications and clinical
outcomes were evaluated. Angiographic success was
defined as when post-embolic angiography demonstrated
cessation of extravasation with no backbleeding from
collateral flow or non-opacification of pseudoaneurysm at
the end of the procedure. Clinical success was defined as
clinical improvement with complete cessation of bleeding
after embolization without the need for emergent surgery
or other interventional procedures. Cessation of bleeding
was defined by clearing of the nasogastric aspirate by 24
hours after embolization or absence of bleeding on
endoscopic examination as well as stabilization of the
hemoglobin level within 48 hours of the embolization
procedure.
Patients who met one of the following criteria were
considered to have a coagulopathy: prothrombin ratio
greater than 1.5, partial thromboplastin time greater than 45
seconds, or platelet count of less than 80,000/ L (2, 6, 7). 
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Fig. 2. Sixty-seven-year-old male with duodenal stent placement for duodenal adenocarcinoma 20 days previously.
A. Celiac arteriography shows suspected extravasation of contrast media into the duodenum (arrow).
B. Gastroduodenal arteriography reveals a pseudoaneurysm of a duodenal branch supplied by the gastroduodenal artery (arrow).
C. The mixture of N-Butyl Cyanoacrylate and lipiodol was injected into the bleeding artery. The radiopaque N-Butyl Cyanoacrylate
mixture accumulated beside the duodenal stent.
D. Post-embolic celiac arteriography shows the successful embolization of the bleeding artery and the preserved blood flow through the
gastroduodenal artery. 
CDRESULTS
In all study patients, it was possible to deliver the NBCA
mixture to the bleeding site; the angiographic success rate
was 100% (32/32). The NBCA mixture was the only
embolic material used to achieve angiographic success in
29 patients. Other embolic agents were used in combina-
tion with NBCA mixture in three patients, microcoils in
two cases and gelatin sponge pieces in one case. Microcoils
were used in combination with NBCA for proximal
blockade of pseudoaneurysms in two cases during our
early experience. Backbleeding from collateral flow after
NBCA embolization occurred in one patient with massive
gastric cancer bleeding and additional embolization of
collateral flow from short gastric artery with gelatin sponge
pieces could effectively stop the backbleeding. 
Clinical success was achieved in 29 patients (91%).
Recurrent bleeding after transcatheter embolization
occurred in three patients (9%). However, a second TAE
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Fig. 3. Fifty-nine-year-old male presented with gastric cancer bleeding.
A. Celiac arteriography shows a area of contrast collection supplied by the right gastroepiploic artery (arrow).
B. Selective right gastroepiploic arteriography reveals pseudoaneurysm formation (arrow).
C. After embolization with the NBCA mixture (arrow), post-embolic celiac arteriography shows the successful embolization of the
bleeding artery.
D. The radiopaque N-Butyl Cyanoacrylate  mixture casting in the right gastroepiploic artery is seen on post-embolic radiography (white
arrow).
CDsuccessfully stopped the rebleeding in two patients and
emergency surgery was performed in one patient. In two
patients with a second TACE, the causes of the bleeding
were large duodenal ulcers in both. A repeat angiography
revealed that the previously embolized vessels were not
recanalized, and that other collateral vessels were responsi-
ble for the rebleeding at the same ulcer lesions that were
previously embolized. 
There was no evidence of symptomatic bowel infarction
or other major complications directly related to NBCA
embolization in any of the patients. Follow up endoscopic
evaluations were performed in 20 patients between 1-105
days (mean 16 days) after the embolization and postem-
bolization bowel ischemia was not observed in any of the
patients.
Twenty-three of 32 patients were discharged after
clinical improvement without surgery. Two patients
underwent surgery for underlying gastric cancer. Seven
patients expired during the hospital course due to other
underlying conditions. Coagulopathy was present at the
time of TAE in 18 patients (56%) and the clinical success
rate in this group of patients was 83% (15/18).
DISCUSSION
Since Rosch et al. (8) introduced the technique of TAE as
an alternative to surgery for the control of upper gastroin-
testinal bleeding in 1972, TAE has gained widespread
acceptance for first-line treatment of acute nonvariceal
upper gastrointestinal bleeding resistant to endoscopic
therapy. TAE is generally preferred over surgery,
especially in high-risk patients (3, 6, 9, 10). The efficacy of
TAE in initial hemostasis of acute nonvariceal gastrointesti-
nal bleeding has been reported to be 52 90%; however,
relatively high rates of rebleeding have also been reported
(3, 6, 7, 10 12). 
A variety of embolic agents such as gelatin sponge
pieces, microcoils, polyvinyl alcohol particles and autolo-
gous blood clots have been used in TAE for gastrointestinal
bleeding. Some authors have reported the use of liquid
adhesives for transcatheter embolization of gastrointestinal
bleeding (11, 13 15). However, most interventional
radiologists are reluctant to use this technique because of
the potential risk of complicated ischemic injury and the
difficulty with handling liquid adhesives. Liquid adhesives
or glue have been used as embolic agents for nearly three
decades, but experience with liquid adhesives outside of
neurological interventions has been generally limited (16). 
N-Butyl Cyanoacrylate is a well known liquid adhesive
used in the vascular system; the US Food and Drug
Administration recently approved its use for cerebral
arteriovenous malformations in 2000. A localized vascular
occlusion mimicking a surgical ligation can be achieved
within seconds as the NBCA polymerizes on exposure to
the anions in blood (17). Unlike temporary embolic agents,
vascular occlusion using NBCA is permanent and cannot
be removed by reversal of vessel flow. NBCA is also easy
to deliver through a microcatheter because of its low
viscosity. However, its lack of radiopacity and its rapid
polymerization time make it difficult to use. The addition
of iodized oil to NBCA can opacify the agent and polymer-
ization time can be tempered with an increased ratio of
iodized oil to NBCA. Stoesslein et al. reported that the
mixture of NBCA and iodized oil at a mixing ratio of 1:3
1:4 provided optimal embolic material with a polymeriza-
tion time of 7.5 11.5 seconds with excellent contrast
definition reported in their experimental study in 1982
(18). However, the in vivo polymerization time for NBCA
appears to be more rapid than the in vitro time because of
the higher body temperature compared to room tempera-
ture and a greater presence of anions intravascularly (19).
Pollak and white suggested that the estimated in vivo
polymerization time for the NBCA to iodized oil mixtures
of between 1:1 and 1:4 were 1 4 seconds, with a linear
relationship between time and mixture ratio (16). In the
present study, we mixed NBCA with iodized oil in ratios
varying from 1:1 to 1:3, and we determined the appropri-
ate amount and dilution of NBCA depending on the size
and shape of the vessel and its distribution after test
injection with contrast material to the target of emboliza-
tion. However, we used the 1:3 mixing ratio in most cases
because the 1:3 ratio was thought to provide a useful
polymerization time for embolization in most patients with
GI bleeding. The test injection took only one or two
minutes and did not cause a significant time delay during
emergency procedures. 
Among the variety of embolic agents, coils are usually
preferred for embolization of pseudoaneurysms.
Superselective catheterization and stable catheter position-
ing are required for safe release and ideal coil emboliza-
tion. However, sometimes it is difficult to selectively place
the catheter close to and beyond the pseudoaneurysm in
small or tortuous vessels (20). Furthermore, when there
are many efferent arteries originating from the pseudoa-
neurysm, or many collateral vessels coming from the
adjacent arteries, the procedure becomes time consuming
and technically difficult to carry out with coils. Although
catheterization may be possible, coils may not be delivered
because of the tortuosity of vessels (20). However, because
of its low viscosity, NBCA can be injected through a
microcatheter into small arteries and collateral circulation,
which are difficult to embolize with a coil. Even though it
Jae et al.
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point, when the microcatheter is tightly engaged in the
bleeding artery, it is possible to deliver NBCA selectively
to the bleeding site without embolizing innocent vessels. 
In the upper gastrointestinal tract there are rich anasto-
moses between adjacent arteries; this had made backbleed-
ing a problem with embolization procedures. For effective
hemostasis, embolization of both feeding arteries and
potential collateral channels is required. However, gelatin
sponge pieces or polyvinyl alcohol particles have a chance
to embolize only the feeding artery and sometimes post-
embolic angiography reveals backbleeding from collateral
channels that are usually more complex and difficult to
access (16). Superselection of those collateral feeders is
very time consuming and can occasionally result in failed
catheterization and embolization. In this series, backbleed-
ing from collateral channels did not occur except in one
case of massive gastric cancer bleeding. This suggests that
NBCA can effectively embolize all potential collateral
channels together with the main feeder vessels with only a
single injection. In cases of life threatening bleeding, the
choice of NBCA as an embolization material can be
lifesaving by minimizing the risk of backbleeding, which
can occur with the use of other embolic materials. Toyoda
et al. reported that the time for TAE, using NBCA, was
significantly faster than for TAE procedures that do not use
NBCA. This is important particularly in cases of massive
bleeding that require urgent hemostasis (11). 
Coagulopathy has been associated with clinical failure
after TAE (2, 6, 7). Encarnacion et al. reported that
embolization was 2.9 times more likely to fail in patients
with coagulopathy, and that death from bleeding after
embolization was 9.6 times more likely to occur in this
group (6). Schenker et al. also reported that embolization
in patients with a coagulopathy at the time of intervention
was 2.8 times more likely to fail, and the odds of dying
were 3.4 times greater for patients with a coagulopathy
(2). In cases of coil or polyvinyl alcohol particle emboliza-
tion, occlusion of vessels or pseudoaneurysms is dependent
on thrombosis rather than the embolic material itself and
the coagulation state of the patient is important for the
ultimate success of the embolization procedure. However,
NBCA does not depend on the coagulation process for its
therapeutic effect and therefore can be used effectively in
patients with a coagulopathy. Eighteen of 32 patients
(56%) in our study had a diagnosis of a coagulopathy prior
to arrival to the angiographic suite; the angiographic
success rate in this group of patients was 100% and the
clinical success rate was 83% in spite of their coagulopa-
thy. Considering that angiographic success rate of TAE in
patients with coagulopathy has been previously reported
to be less than 46%, NBCA appears to provide a more
successful approach in patients with a coagulopathy (2, 6).
Transcatheter embolization with NBCA has the potential
risk of complications including: embolization of the
proximal segment without adequate embolization at the
bleeding site due to rapid polymerization, distal emboliza-
tion of untargeted sites due to too rapid injection of the
NBCA mixture or an excessively prolonged polymeriza-
tion time (21) and reflux of glue into another innocent
vessel by overinjection. Complications related to NBCA
embolization can be minimized by careful attention to the
specific vascular anatomy and the information obtained
from test injections with contrast material. In this series,
none of these patients developed symptomatic bowel
infarction or mesenteric ischemia after NBCA emboliza-
tion. These results correlate well with the experience of
Yamakado et al. (20) and Kish et al. (13) who similarly had
no cases of organ infarction. 
In order to carry out a precise and safe embolization and
to reduce the possibility of complications with the use of
NBCA as an embolic material, we recommend the follow-
ing: 1) Pay careful attention to the specific vascular
anatomy and the information obtained from the test
injections with contrast media; 2) Use the wedged catheter
technique with no pericatheter flow. It allows the interven-
tional radiologists to precisely control the extent of glue
embolization; 3) Perform a simulated injection with
contrast media in the same condition before the actual
NBCA injection with precise volume calculation. 
The single use of a microcatheter, without flushing after
NBCA injection, is highly recommended for precise
embolization with the wedged technique because overin-
jection of NBCA can occur during flushing of the
microcatheter. The intraluminal volume of microcathter is
usually around 0.3 mL and this should be considered for
precise volume estimation. For example, if initially 0.8 mL
of NBCA mixture was drawn up in a 1-mL syringe and 0.1
mL was left in the syringe after injection, then 0.4 mL was
injected into the embolized vessels and 0.3 mL was left in
the discarded microcatheter. Adequate experience and
training are also mandatory for successful NBCA
embolization without major complications. Although most
interventional radiologists are familiar with the use of coils
and particles such as gelatin sponge pieces and polyvinyl
alcohol, few have experience with liquid adhesives such as
NBCA (16). NBCA is difficult to use initially, however
after becoming familiar with its properties in the animal
laboratory, it can be used safely for the care of patients. 
In conclusion, TAE with NBCA is a highly effective and
safe treatment modality for upper gastrointestinal
bleeding, especially in cases when it is technically difficult
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to advance the microcatheter to the bleeding site and in
patients with a coagulopathy.
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